Literature DB >> 7491393

Haloperidol-related dyskinesias and pre- and perinatal complications in autistic children.

J L Armenteros1, P B Adams, M Campbell, Z W Eisenberg.   

Abstract

It has been hypothesized that an association exists between pre- and perinatal complications, central nervous system (CNS) dysfunction, and the development of tardive (TD) and withdrawal dyskinesias (WD). We assessed the relationship between pre- and perinatal complications and TD/WD in a sample of 118 children with autism who participated in an ongoing long-term prospective study of the efficacy and safety of haloperidol. The mean total Rochester Research Obstetrical Scale (ROS) score was significantly higher for children who developed TD/WD compared to those who did not (p = .007) as was the mean score of the ROS Delivery Scale (p = .002). Anesthesia during delivery was more frequent in children who developed TD/WD (25 of 40, 62.5%) than in those who did not (30 of 78, 38.5%) (p = .019). The ROS Not Vertex Presentation item and TD/WD were associated only in females (p = .019). Six of 7 males with short labor developed TD/WD (p = .007). ROS scores did not differ significantly as a function of gender or socio-economic status (SES). Pre- and perinatal complications appear to be related to the development of TD/WD in this sample of children.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7491393

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN: 0048-5764


  5 in total

Review 1.  Prognosis in autism: do specialist treatments affect long-term outcome?

Authors:  P Howlin
Journal:  Eur Child Adolesc Psychiatry       Date:  1997-06       Impact factor: 4.785

2.  Tardive dyskinesia and pregnancy and delivery complications.

Authors:  M H El-DeFrawi; G Hirsch; A Jurkowicz; T J Craig
Journal:  Child Psychiatry Hum Dev       Date:  1996

Review 3.  Antipsychotics in the treatment of autism.

Authors:  David J Posey; Kimberly A Stigler; Craig A Erickson; Christopher J McDougle
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

Review 4.  Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia.

Authors:  Hanna Bergman; John Rathbone; Vivek Agarwal; Karla Soares-Weiser
Journal:  Cochrane Database Syst Rev       Date:  2018-02-06

Review 5.  Aggression in autism spectrum disorder: presentation and treatment options.

Authors:  Sarah E Fitzpatrick; Laura Srivorakiat; Logan K Wink; Ernest V Pedapati; Craig A Erickson
Journal:  Neuropsychiatr Dis Treat       Date:  2016-06-23       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.